The trial aimed to evaluate the accuracy of an artificial intelligence-based system for diagnosing depressive disorders. Specifically, it sought to determine whether the system's assessment validity is non-inferior to that of psychiatric specialists.
Subjects with anxiety disorders （1）
In accordance with ICD-11 for Depressive Disorders;
Between the ages of 18-60;
Ability to use computers or smartphone;
With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;
With a high risk of suicide or self-injury;
With severe physical diseases, central nervous system diseases, or substance abuse;
With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.